Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic

Bin Shi1, Deeksha Vishwamitra, J Gabrielle Granda

  • 1Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Neoplasia (New York, N.Y.)
|June 5, 2013
PubMed

Insights

Dual mutation of Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) at Tyr(644) and Tyr(664) abrogates its association with insulin-like growth factor receptor (IGF-IR). This dual mutation significantly diminishes NPM-ALK

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Aberrant expression of Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) drives T cell lymphoma in young individuals.
  • NPM-ALK exhibits potent oncogenic activity, but its precise mechanisms remain unclear.
  • NPM-ALK physically associates with type I insulin-like growth factor receptor (IGF-IR), forming a positive feedback loop.

Purpose of the Study:

  • To investigate if dual mutation of NPM-ALK at Tyr(644) and Tyr(664) abrogates its association with IGF-IR.
  • To assess the impact of this dual mutation on NPM-ALK's oncogenic potential.

Main Methods:

  • Site-directed mutagenesis to create NPM-ALK(Y644,664F) mutant.
  • Assessment of NPM-ALK and IGF-IR association.
  • Evaluation of cellular transformation, proliferation, migration, and anchorage-independent colony formation assays.

Main Results:

  • NPM-ALK(Y644,664F) completely lacks association with IGF-IR.
  • The dual mutation significantly diminishes NPM-ALK's oncogenic effects, including colony formation, cellular transformation, proliferation, and migration.
  • The Tyr(644)/Tyr(664) residues are crucial for NPM-ALK protein stability and its interaction with IGF-IR.

Conclusions:

  • The association between NPM-ALK and IGF-IR, mediated by Tyr(644) and Tyr(664), is critical for NPM-ALK's oncogenic activity in T cell lymphoma.
  • Targeting this NPM-ALK/IGF-IR interaction may offer a therapeutic strategy for aggressive lymphomas.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...